|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetes Mellitus, Type 2 | |||||
| Heart Failure, Congestive | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Heart Failure | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Heart Diseases | |||||
| Metabolic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Metformin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hypoglycemic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Alberta | |||||